4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001329505-26-000007
Director acquired 8,437,472 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bailey Gregory Director | 2026-06-17 | Conversion | +1,770,805 | $2.25 | $3,984,311 | 1,897,445 | D: show line 1 in the form |
| Bailey Gregory Director | 2026-06-17 | Conversion | +6,666,667 | $2.25 | $14,999,334 | 8,564,382 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bailey Gregory Director | 2026-06-17 | Grant or award · Stock Option (right to buy) | +15,250 | 15,250 | D: show line 3 in the form | ||
| Bailey Gregory Director | 2026-06-17 | Grant or award · Redeemable Warrants | +3,333,333 | 3,333,333 | D: show line 4 in the form | ||
| Bailey Gregory Director | 2026-06-17 | Conversion · Series A Convertible Preferred Stock | −762,548 | $2.25 | $1,715,733 | 0 | D: show line 5 in the form |
Loading xslF345X06/wk-form4_1782170066.xml…